Logo image of ZEN.CA

ZENTEK LTD (ZEN.CA) Stock Fundamental Analysis

TSX-V:ZEN - TSX Venture Exchange - CA98942X1024 - Common Stock - Currency: CAD

1.54  -0.01 (-0.65%)

Fundamental Rating

2

Overall ZEN gets a fundamental rating of 2 out of 10. We evaluated ZEN against 15 industry peers in the Health Care Equipment & Supplies industry. The financial health of ZEN is average, but there are quite some concerns on its profitability. ZEN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ZEN has reported negative net income.
ZEN had a negative operating cash flow in the past year.
ZEN had negative earnings in each of the past 5 years.
ZEN had a negative operating cash flow in each of the past 5 years.
ZEN.CA Yearly Net Income VS EBIT VS OCF VS FCFZEN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

The Return On Assets of ZEN (-50.52%) is better than 80.00% of its industry peers.
Looking at the Return On Equity, with a value of -57.83%, ZEN is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
ROA -50.52%
ROE -57.83%
ROIC N/A
ROA(3y)-55.19%
ROA(5y)-53.2%
ROE(3y)-60.58%
ROE(5y)-96.95%
ROIC(3y)N/A
ROIC(5y)N/A
ZEN.CA Yearly ROA, ROE, ROICZEN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

ZEN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZEN.CA Yearly Profit, Operating, Gross MarginsZEN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50K -100K -150K

More info and screens

5

2. Health

2.1 Basic Checks

ZEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZEN has more shares outstanding than it did 1 year ago.
ZEN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ZEN has a worse debt to assets ratio.
ZEN.CA Yearly Shares OutstandingZEN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ZEN.CA Yearly Total Debt VS Total AssetsZEN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 29.22 indicates that ZEN is not in any danger for bankruptcy at the moment.
ZEN's Altman-Z score of 29.22 is amongst the best of the industry. ZEN outperforms 100.00% of its industry peers.
ZEN has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
ZEN has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. ZEN outperforms 93.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 29.22
ROIC/WACCN/A
WACC7.76%
ZEN.CA Yearly LT Debt VS Equity VS FCFZEN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 2.06 indicates that ZEN has no problem at all paying its short term obligations.
ZEN's Current ratio of 2.06 is fine compared to the rest of the industry. ZEN outperforms 66.67% of its industry peers.
ZEN has a Quick Ratio of 1.63. This is a normal value and indicates that ZEN is financially healthy and should not expect problems in meeting its short term obligations.
ZEN has a Quick ratio of 1.63. This is in the better half of the industry: ZEN outperforms 73.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 1.63
ZEN.CA Yearly Current Assets VS Current LiabilitesZEN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

ZEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.53%, which is quite good.
ZEN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.16%.
Measured over the past years, ZEN shows a very strong growth in Revenue. The Revenue has been growing by 132.92% on average per year.
EPS 1Y (TTM)15.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.03%
Revenue 1Y (TTM)8.16%
Revenue growth 3Y132.92%
Revenue growth 5YN/A
Sales Q2Q%34.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZEN.CA Yearly Revenue VS EstimatesZEN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
ZEN.CA Yearly EPS VS EstimatesZEN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZEN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZEN.CA Price Earnings VS Forward Price EarningsZEN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZEN.CA Per share dataZEN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZEN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZENTEK LTD

TSX-V:ZEN (2/12/2025, 7:00:00 PM)

1.54

-0.01 (-0.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-23 2024-02-23/amc
Earnings (Next)N/A N/A
Inst Owners1%
Inst Owner ChangeN/A
Ins Owners5.79%
Ins Owner ChangeN/A
Market Cap160.22M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4070.67
P/FCF N/A
P/OCF N/A
P/B 8.63
P/tB 8.63
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS0.18
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.52%
ROE -57.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-55.19%
ROA(5y)-53.2%
ROE(3y)-60.58%
ROE(5y)-96.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 28.03%
Cap/Sales 448.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.06
Quick Ratio 1.63
Altman-Z 29.22
F-Score4
WACC7.76%
ROIC/WACCN/A
Cap/Depr(3y)388.68%
Cap/Depr(5y)1742.24%
Cap/Sales(3y)2084.26%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.03%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.16%
Revenue growth 3Y132.92%
Revenue growth 5YN/A
Sales Q2Q%34.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.95%
OCF growth 3YN/A
OCF growth 5YN/A